Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03112694
Recruitment Status : Completed
First Posted : April 13, 2017
Last Update Posted : December 21, 2018
Sponsor:
Information provided by (Responsible Party):
Ipsen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2, 2017
Actual Study Completion Date : November 2, 2017